Reduced polymorphism in the kelch propeller domain in plasmodium vivax isolates from Cambodia

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 1, 2015, Pages 730-733

  Popovici, Jean ^a   Kao, Sokheng ^a   Eal, Leanghor ^a   Bin, Sophalai ^a   Kim, Saorin ^a   Ménard, Didier ^a  

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

8 DIFLUOROMETHOXY 1 ETHYL 6 FLUORO 1,4 DIHYDRO 7 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 4 OXO 3 QUINOLINECARBOXYLIC ACID; ARTEMISININ; CHLOROQUINE; TRANQUILIZER;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CAMBODIA; CODON; DNA POLYMORPHISM; GENE ISOLATION; GENE MUTATION; MULTIDRUG RESISTANCE; NONHUMAN; ORTHOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTOZOAL GENETICS; WILD TYPE; DRUG RESISTANCE; GENE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALARIA, VIVAX; MICROBIOLOGY; SEQUENCE ALIGNMENT;

ANTIMANIC AGENTS; CAMBODIA; DRUG RESISTANCE; GENES, PROTOZOAN; HUMANS; MALARIA, VIVAX; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; SEQUENCE ALIGNMENT;

EID: 84920186396     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03908-14     Document Type: Article

References (21)

1. Imwong M, Nakeesathit S, Day NP, White NJ. 2011. A review of mixed malaria species infections in anopheline mosquitoes. Malar J 10:253. http: //dx.doi.org/10.1186/1475-2875-10-253.
2. Mayxay M, Pukrittayakamee S, Newton PN, White NJ. 2004. Mixedspecies malaria infections in humans. Trends Parasitol 20:233-240. http: //dx.doi.org/10.1016/j.pt.2004.03.006.
3. Nei M. 2013. Mutation-driven evolution. Oxford University Press, Oxford, United Kingdom.
4. Hawkins VN, Joshi H, Rungsihirunrat K, Na-Bangchang K, Sibley CH. 2007. Antifolates can have a role in the treatment of Plasmodium vivax. Trends Parasitol 23:213-222. http://dx.doi.org/10.1016/j.pt.2007.03.002.
5. Khim N, Andrianaranjaka V, Popovici J, Kim S, Ratsimbasoa A, Benedet C, Barnadas C, Durand R, Thellier M, Legrand E, Musset L, Menegon M, Severini C, Nour BYM, Tichit M, Bouchier C, Mercereau- Puijalon O, Ménard D. 2014. Effects of mefloquine use on Plasmodium vivax multidrug resistance. Emerg Infect Dis 20:1629-1636. http://dx.doi .org/10.3201/eid2010.140411.
6. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TJ, Fay MP, Mu J, Duong S, Fairhurst RM. 2012. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis 12:851-858. http://dx.doi.org/10.1016/S1473-3099(12) 70181-0.
7. Amaratunga C, Witkowski B, Khim N, Menard D, Fairhurst RM. 2014. Artemisinin resistance in Plasmodium falciparum. Lancet Infect Dis 14: 449-450. http://dx.doi.org/10.1016/S1473-3099(14)70777-7.
8. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Menard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Menard D. 2014. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505:50-55. http://dx.doi.org/10.1038/nature12876.
9. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ. 2009. Artemisinin resistance in Plasmodium falciparum malaria.NEngl J Med 361:455-467. http: //dx.doi.org/10.1056/NEJMoa0808859.
10. Hien TT, Thuy-Nhien NT, Phu NH, Boni MF, Thanh NV, Nha-Ca NT, Thai LH, Thai CQ, Toi PV, Thuan PD, Long LT, Dong LT, Merson TL, Dolecek C, Stepniewska K, Ringwald P, White NJ, Farrar J, Wolbers M. 2012. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J 11:355. http://dx.doi.org/10.1186/1475 -2875-11-355.
11. Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Aye MM, Lindegardh N, Tarning J, Imwong M, Jacob CG, Rasmussen C, Perin J, Ringwald P, Nyunt MM. 2013. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One 8:e57689. http://dx.doi.org /10.1371/journal.pone.0057689.
12. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359:2619-2620. http://dx.doi.org/10.1056/NEJMc0805011.
13. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F. 2012. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379:1960 -1966. http://dx.doi.org/10.1016 /S0140-6736(12)60484-X.
14. Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, Lim P, Mao S, Sopha C, Sam B, Anderson JM, Duong S, Chuor CM, Taylor WR, Suon S, Mercereau-Puijalon O, Fairhurst RM, Menard D. 2013. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis 13:1043-1049. http://dx.doi.org/10.1016/S1473 -3099(13)70252-4.
15. Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D. 2013. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother 57:914-923. http://dx.doi.org/10.1128/AAC.01868-12.
16. Mitsuishi Y, Motohashi H, Yamamoto M. 2012. The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front Oncol 2:200. http://dx.doi.org/10.3389/fonc.2012.00200.
17. Fidock DA, Eastman RT, Ward SA, Meshnick SR. 2008. Recent highlights in antimalarial drug resistance and chemotherapy research. Trends Parasitol 24:537-544. http://dx.doi.org/10.1016/j.pt.2008.09.005.
18. Lehane AM, McDevitt CA, Kirk K, Fidock DA. 2012. Degrees of chloroquine resistance in Plasmodium-is the redox system involved? Int J Parasitol Drugs Drug Resist 2:47-57. http://dx.doi.org/10.1016/j.ijpddr .2011.11.001.
19. Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, Ringwald P. 2013. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Antimicrob Agents Chemother 57:818-826. http://dx.doi.org/10.1128/AAC.00686-12.
20. Canier L, Khim N, Kim S, Sluydts V, Heng S, Dourng D, Eam R, Chy S, Khean C, Loch K, Ken M, Lim H, Siv S, Tho S, Masse-Navette P, Gryseels C, Uk S, Van Roey K, Grietens KP, Sokny M, Thavrin B, Chuor CM, Deubel V, Durnez L, Coosemans M, Menard D. 2013. An innovative tool for moving malaria PCR detection of parasite reservoir into the field. Malar J 12:405. http://dx.doi.org/10.1186/1475-2875-12 -405.
21. Goncalves LA, Cravo P, Ferreira MU. 2014. Emerging Plasmodium vivax resistance to chloroquine in South America: an overview. Mem Inst Oswaldo Cruz 109:534-539. http://dx.doi.org/10.1590/0074-0276130579.